Company

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals is a New York biopharmaceutical company developing therapeutics across several therapeutic areas.

About

Headquartered in New York, US, Tonix Pharmaceuticals Holding Corp. develops therapeutics for central nervous system disorders, immunology, infectious diseases and rare diseases. On June 22, 2022, it secured USD 30.00 mn in PIPE funding, and it has completed 7 deals to date. In 2024 the company reported revenue of USD 10.09 mn and an EBITDA of USD -133.28 mn. The company is listed as Public.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in